Harbin Pharmaceutical Group Co., Ltd. (600664.SS)
Shanghai - Shanghai Delayed Price. Currency in CNY
Add to watchlist
3.0200+0.0300 (+1.00%)
At close: 3:00PM CST
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 2.9900 |
| Open | 2.9800 |
| Bid | 3.0100 x 0 |
| Ask | 3.0200 x 0 |
| Day's Range | 2.9300 - 3.0500 |
| 52 Week Range | 2.3800 - 4.3600 |
| Volume | 24,545,210 |
| Avg. Volume | 23,961,126 |
| Market Cap | 7.604B |
| Beta (5Y Monthly) | 0.26 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.3190 |
| Earnings Date | Aug 24, 2021 - Aug 30, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | May 04, 2018 |
| 1y Target Est | 22.12 |
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
- Reuters
U.S. senator asks for CFIUS review of GNC purchase by Chinese company
U.S. Senator Marco Rubio, a Republican and a China hawk, asked for a national security review of plans by General Nutrition Centers <GNC.N>, or GNC, to sell itself to Harbin Pharmaceutical Group Co Ltd. Rubio, who had also urged a probe of TikTok's ownership by another Chinese firm, made the request in a letter to Treasury Secretary Steven Mnuchin. GNC, a health and nutrition products retailer, has said it has agreed in principle with many lenders to sell itself to an affiliate of its largest shareholder, Harbin Pharmaceutical <600664.SS>, for $760 million in a court-supervised auction, subject to higher bids.
© 2021 Verizon Media. All rights reserved.
